Cardiovascular imaging in 2024: review of current research and innovations.

Journal: European heart journal. Imaging methods and practice
Published Date:

Abstract

Cardiovascular imaging saw significant advancements in 2024, impacting technology, pathophysiology, and clinical applications. This review provides a comprehensive summary of the most impactful research in cardiovascular imaging published in 2024, highlighting technological advancements, as well as research on ischaemic heart disease, valvular heart disease, cardiomyopathies, and heart failure. It emphasizes the crucial role of artificial intelligence, large-scale studies, and technical improvements across echocardiography, cardiovascular magnetic resonance, computed tomography (CT), and nuclear medicine. In the context of ischaemic heart disease, non-invasive imaging strategies improve patient management and reduce invasive coronary angiograms and unnecessary follow-up testing. Computed tomography plaque characterization is a growing area of research, with potential for predicting disease severity, atherosclerosis progression, and clinical outcomes. In valvular heart disease, several imaging studies focused not only on transcatheter treatments for aortic stenosis, mitral regurgitation, and tricuspid regurgitation but also on specific conditions such as mitral valve prolapse and mitral annular disjunction. Finally, for heart failure and cardiomyopathies, imaging plays a vital role in early diagnosis and risk assessment, with newer techniques surpassing traditional methods in providing morpho-function characterization and in predicting long-term outcomes.

Authors

  • Andrea Barison
    Cardiology and Cardiovascular Medicine, Fondazione Toscana Gabriele Monasterio, Pisa.
  • Ana Teresa Timoteo
    Cardiology Department, Santa Marta Hospital, Unidade Local Saúde São José, Lisbon, Portugal.
  • Saloua El Messaoudi
    Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands (T.S.J.O., A.v.B., S.E.M., J.H.C.).
  • Sonia Borodzicz-Jazdzyk
    First Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
  • Sara Moscatelli
    Inherited Cardiovascular Diseases, Great Ormond Street Hospital, Children NHS Foundation Trust, London, UK.
  • Giulia Elena Mandoli
    Department of Medical Biotechnologies, Division of Cardiology, University of Siena, 53100, Siena, Italy.
  • Christina Luong
  • Eylem Levelt
    The Baker Heart and Diabetes Institute and University of Melbourne, Melbourne, Australia.
  • Arti Anushka Ramkisoensing
    Department of Cardiology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
  • Zahra Raisi-Estabragh
    William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, United Kingdom (A.S., A.M.L., Z.R.-E., S.E.P.).
  • Alexios Antonopoulos
  • Sarah Moharem-Elgamal
    Cardiology Department, Liverpool Heart and Chest Hospital and Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool, United Kingdom.
  • Riccardo Liga
    Cardiology Department, University of Pisa, Pisa, Italy.
  • Gianluca Pontone
    Department of Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Milan, Italy.
  • Danilo Neglia
    Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, Via Moruzzi 1, 56124 Pisa, Italy.

Keywords

No keywords available for this article.